Possible involvement of K(ATP) channel activation in depressor responses to vasoactive neuropeptides in rats

Japanese Journal of Pharmacology

Volumn 76, Issue 2, 1998, Pages 227-231

  Saito, Keiji ^a   Sakai, Kazushige ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Depressor response; K(ATP) channel activation; Neuropeptide

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; CALCITONIN GENE RELATED PEPTIDE; CROMAKALIM; GLIBENCLAMIDE; NEUROPEPTIDE; POTASSIUM CHANNEL; SUBSTANCE P; VASOACTIVE AGENT; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0031935596     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.227     Document Type: Article

References (15)

1. Rubino A and Burnstock G: Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc Res 31, 469-479 (1996)
2. Mulderry PK, Ghatei MA, Rodrigo J, Allen JM, Rosenfeld MG, Polak JM and Bloom SR: Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience 14, 947-954 (1985)
3. + Channels in Cardiovascular Medicine, Edited by Escande D and Standen NB, pp 95-106, Springer-Verlag, Paris (1993)
4. Hamilton TC and Weston AH: Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 20, 1-9 (1989)
5. Saito K and Sakai K: Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim. Fundam Clin Pharmacol 12, 37-43 (1998)
6. Elhawary AM, Poon J and Pang CCY: Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin. Br J Pharmacol 115, 1133-1140 (1995)
7. 2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein. Eur J Pharmacol 236, 255-262 (1993)
8. Cavero I, Mondot S and Mestre M: Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 248, 1261-1268 (1989)
9. Clapham JC, Hamilton TC, Longman SD, Buckingham RE and Campbell CA: Antihypertensive and haemodynamic properties of the potassium channel activating (-)enantiomer of cromakalim in animal models. Arzneimittelforschung 41, 385-391 (1991)
10. + channels. Nature 344, 770-773 (1990)
11. + channels in CGRP-induced dilatation of basilar artery in vivo. Am J Physiol 265, H581-H585 (1993)
12. + channels in arterial smooth muscle. Science 245, 177-180 (1989)
13. Furchgott RF: Role of endothelium in responses of vascular smooth muscle. Circ Res 53, 557-573 (1983)
14. Pernow J: Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium. Br J Pharmacol 97, 983-989 (1989)
15. +-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery. Br J Pharmacol 102, 585-594 (1991)